Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Prognostic value and therapeutic implications of expanded molecular testing for resected early stage lung adenocarcinoma.

Kneuertz PJ, Carbone DP, D'Souza DM, Shilo K, Abdel-Rasoul M, Zhao W, Williams TM, Jones D, Merritt RE.

Lung Cancer. 2020 Mar 18;143:60-66. doi: 10.1016/j.lungcan.2020.03.012. [Epub ahead of print]

PMID:
32208298
2.

Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations.

Baek J, Owen DH, Merritt RE, Shilo K, Otterson GA, D'Souza DM, Carbone DP, Kneuertz PJ.

Clin Lung Cancer. 2020 Feb 25. pii: S1525-7304(20)30041-3. doi: 10.1016/j.cllc.2020.02.016. [Epub ahead of print] No abstract available.

PMID:
32184051
3.
4.

Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice.

Duan W, Gao L, Kalvala A, Aguila B, Brooks C, Mo X, Ding H, Shilo K, Otterson GA, Villalona-Calero MA.

Int J Cancer. 2019 Nov 1;145(9):2418-2426. doi: 10.1002/ijc.32279. Epub 2019 Apr 13.

PMID:
30873587
5.

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC.

Arasada RR, Shilo K, Yamada T, Zhang J, Yano S, Ghanem R, Wang W, Takeuchi S, Fukuda K, Katakami N, Tomii K, Ogushi F, Nishioka Y, Talabere T, Misra S, Duan W, Fadda P, Rahman MA, Nana-Sinkam P, Evans J, Amann J, Tchekneva EE, Dikov MM, Carbone DP.

Nat Commun. 2018 Aug 10;9(1):3198. doi: 10.1038/s41467-018-05626-2.

6.

Bilateral Lung Masses and Dyspnea in a Young Woman.

Hay BR, Shilo K, Englert JA.

Ann Am Thorac Soc. 2018 Jul;15(7):875-879. doi: 10.1513/AnnalsATS.201801-066CC. No abstract available.

PMID:
29957041
7.

Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma.

Owen D, Chu B, Lehman AM, Annamalai L, Yearley JH, Shilo K, Otterson GA.

J Thorac Oncol. 2018 Aug;13(8):1204-1212. doi: 10.1016/j.jtho.2018.04.013. Epub 2018 Apr 24.

8.

Comprehensive Next-Generation Sequencing Analysis is Recommended for the Management of Patients With Melanoma.

Yao K, Zhao W, Bajestani S, Gru A, Otterson G, Shilo K.

Appl Immunohistochem Mol Morphol. 2018 Feb;26(2):e24-e25. doi: 10.1097/PAI.0000000000000607. No abstract available.

PMID:
29176444
9.

Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations.

Yamada T, Amann JM, Tanimoto A, Taniguchi H, Shukuya T, Timmers C, Yano S, Shilo K, Carbone DP.

Mol Cancer Ther. 2018 Jan;17(1):17-25. doi: 10.1158/1535-7163.MCT-17-0146. Epub 2017 Oct 27.

10.

Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid Biopsy.

Shukuya T, Patel S, Shane-Carson K, He K, Bertino EM, Shilo K, Otterson GA, Carbone DP.

J Thorac Oncol. 2018 Feb;13(2):e17-e19. doi: 10.1016/j.jtho.2017.09.1962. Epub 2017 Oct 5. No abstract available.

11.

Malignant Melanoma Presenting as Thoracic Midline Malignancy: Clinicopathologic and Molecular Features.

Yao K, Zhao W, Bajestani S, Gru A, Otterson G, Shilo K.

Appl Immunohistochem Mol Morphol. 2018 Jan;26(1):46-53. doi: 10.1097/PAI.0000000000000546.

PMID:
28777149
12.

Papillary fibroelastoma arising from the coumadin ridge.

Malik M, Shilo K, Kilic A.

J Cardiovasc Thorac Res. 2017;9(2):118-120. doi: 10.15171/jcvtr.2017.20. Epub 2017 Apr 12.

13.

Crospovidone and Microcrystalline Cellulose: A Novel Description of Pharmaceutical Fillers in the Gastrointestinal Tract.

Shaddy SM, Arnold MA, Shilo K, Frankel WL, Harzman AE, Stanich PP, Singhi AD, Yearsley MM, Arnold CA.

Am J Surg Pathol. 2017 Apr;41(4):564-569. doi: 10.1097/PAS.0000000000000790.

PMID:
28009603
14.

Proteomic Signatures of Thymomas.

Wang L, Branson OE, Shilo K, Hitchcock CL, Freitas MA.

PLoS One. 2016 Nov 10;11(11):e0166494. doi: 10.1371/journal.pone.0166494. eCollection 2016.

15.

Extracellular mRNA Detected by Tethered Lipoplex Nanoparticle Biochip for Lung Adenocarcinoma Detection.

Lee LJ, Yang Z, Rahman M, Ma J, Kwak KJ, McElroy J, Shilo K, Goparaju C, Yu L, Rom W, Kim TK, Wu X, He Y, Wang K, Pass HI, Nana-Sinkam SP.

Am J Respir Crit Care Med. 2016 Jun 15;193(12):1431-3. doi: 10.1164/rccm.201511-2129LE. No abstract available.

16.

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer.

Elbaz M, Ahirwar D, Xiaoli Z, Zhou X, Lustberg M, Nasser MW, Shilo K, Ganju RK.

Oncotarget. 2016 May 27;9(71):33459-33470. doi: 10.18632/oncotarget.9663. eCollection 2018 Sep 11.

17.

Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature.

Siegele BJ, Shilo K, Chao BH, Carbone DP, Zhao W, Ioffe O, Franklin WA, Edelman MJ, Aisner DL.

Lung Cancer. 2016 May;95:65-72. doi: 10.1016/j.lungcan.2016.02.012. Epub 2016 Feb 26. Review.

18.

Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair.

Villalona-Calero MA, Duan W, Zhao W, Shilo K, Schaaf LJ, Thurmond J, Westman JA, Marshall J, Xiaobai L, Ji J, Rose J, Lustberg M, Bekaii-Saab T, Chen A, Timmers C.

J Natl Cancer Inst. 2016 Feb 4;108(7). doi: 10.1093/jnci/djv437. Print 2016 Jul.

19.

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer.

Bell EH, Chakraborty AR, Mo X, Liu Z, Shilo K, Kirste S, Stegmaier P, McNulty M, Karachaliou N, Rosell R, Bepler G, Carbone DP, Chakravarti A.

Clin Cancer Res. 2016 May 15;22(10):2396-404. doi: 10.1158/1078-0432.CCR-15-1468. Epub 2015 Dec 15.

20.

TRIM72 modulates caveolar endocytosis in repair of lung cells.

Nagre N, Wang S, Kellett T, Kanagasabai R, Deng J, Nishi M, Shilo K, Oeckler RA, Yalowich JC, Takeshima H, Christman J, Hubmayr RD, Zhao X.

Am J Physiol Lung Cell Mol Physiol. 2016 Mar 1;310(5):L452-64. doi: 10.1152/ajplung.00089.2015. Epub 2015 Dec 4.

21.

Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency.

Araujo LH, Timmers C, Shilo K, Zhao W, Zhang J, Yu L, Natarajan TG, Miller CJ, Yilmaz AS, Liu T, Amann J, Lapa E Silva JR, Ferreira CG, Carbone DP.

PLoS One. 2015 Nov 25;10(11):e0143092. doi: 10.1371/journal.pone.0143092. eCollection 2015.

22.

52-Year-Old Male With Upper Lobe Predominant Cystic Lung Disease Requiring Bilateral Lung Transplantation.

Beal EW, Shilo K, Hayes D Jr, Pope-Harman AL.

Am J Transplant. 2015 Dec;15(12):3268-70. doi: 10.1111/ajt.13501. No abstract available.

23.

PDL1 Regulation by p53 via miR-34.

Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, Araujo L, Carbone DP, Shilo K, Giri DK, Kelnar K, Martin D, Komaki R, Gomez DR, Krishnan S, Calin GA, Bader AG, Welsh JW.

J Natl Cancer Inst. 2015 Nov 17;108(1). pii: djv303. doi: 10.1093/jnci/djv303. Print 2016 Jan.

24.

CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung.

Ozkan E, West A, Dedelow JA, Chu BF, Zhao W, Yildiz VO, Otterson GA, Shilo K, Ghosh S, King M, White RD, Erdal BS.

AJR Am J Roentgenol. 2015 Nov;205(5):1016-25. doi: 10.2214/AJR.14.14147.

PMID:
26496549
25.

Metastatic Squamous Cell Carcinoma Component from an Adenosquamous Carcinoma of the Lung with Identical Epidermal Growth Factor Receptor Mutations.

Burkart J, Shilo K, Zhao W, Ozkan E, Ajam A, Otterson GA.

Case Rep Pulmonol. 2015;2015:283875. doi: 10.1155/2015/283875. Epub 2015 Aug 23.

26.

Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled Analysis.

Araujo LH, Lammers PE, Matthews-Smith V, Eisenberg R, Gonzalez A, Schwartz AG, Timmers C, Shilo K, Zhao W, Natarajan TG, Zhang J, Yilmaz AS, Liu T, Coombes K, Carbone DP.

J Thorac Oncol. 2015 Oct;10(10):1430-6. doi: 10.1097/JTO.0000000000000650.

27.

Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant Mesothelioma.

Yamada T, Amann JM, Fukuda K, Takeuchi S, Fujita N, Uehara H, Iwakiri S, Itoi K, Shilo K, Yano S, Carbone DP.

Cancer Res. 2015 Oct 1;75(19):4188-97. doi: 10.1158/0008-5472.CAN-15-0858. Epub 2015 Aug 20.

28.

Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients.

Bertino EM, Williams TM, Nana-Sinkam SP, Shilo K, Chatterjee M, Mo X, Rahmani M, Phillips GS, Villalona-Calero MA, Otterson GA.

Clin Lung Cancer. 2015 Nov;16(6):466-74. doi: 10.1016/j.cllc.2015.05.004. Epub 2015 May 13.

29.

Expression Analysis of p16, c-Myc, and mSin3A in Non-small Cell Lung Cancer by Computer Aided Scoring and Analysis (CASA).

Salmaninejad A, Estiar MA, Gill RK, Shih JH, Hewitt S, Jeon HS, Fukuoka J, Shilo K, Shakoori A, Jen J.

Clin Lab. 2015;61(5-6):549-59.

PMID:
26118188
30.

Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing.

Araujo LH, Timmers C, Bell EH, Shilo K, Lammers PE, Zhao W, Natarajan TG, Miller CJ, Zhang J, Yilmaz AS, Liu T, Coombes K, Amann J, Carbone DP.

J Clin Oncol. 2015 Jun 10;33(17):1966-73. doi: 10.1200/JCO.2014.59.2444. Epub 2015 Apr 27.

31.

Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.

Powell CA, Nasser MW, Zhao H, Wochna JC, Zhang X, Shapiro C, Shilo K, Ganju RK.

Oncotarget. 2015 Mar 20;6(8):6373-85.

32.

Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.

Elbaz M, Nasser MW, Ravi J, Wani NA, Ahirwar DK, Zhao H, Oghumu S, Satoskar AR, Shilo K, Carson WE 3rd, Ganju RK.

Mol Oncol. 2015 Apr;9(4):906-19. doi: 10.1016/j.molonc.2014.12.010. Epub 2015 Jan 19.

33.

RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.

Nasser MW, Wani NA, Ahirwar DK, Powell CA, Ravi J, Elbaz M, Zhao H, Padilla L, Zhang X, Shilo K, Ostrowski M, Shapiro C, Carson WE 3rd, Ganju RK.

Cancer Res. 2015 Mar 15;75(6):974-85. doi: 10.1158/0008-5472.CAN-14-2161. Epub 2015 Jan 8.

34.

Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations.

Yilmaz A, Mohamed N, Patterson KA, Tang Y, Shilo K, Villalona-Calero MA, Davis ME, Zhou X, Frankel W, Otterson GA, Beall HD, Zhao W.

Int J Environ Res Public Health. 2014 Sep 12;11(9):9491-502. doi: 10.3390/ijerph110909491.

35.

Clinical and metabolic parameters in non-small cell lung carcinoma and colorectal cancer patients with and without KRAS mutations.

Yilmaz A, Mohamed N, Patterson KA, Tang Y, Shilo K, Villalona-Calero MA, Davis ME, Zhou XP, Frankel W, Otterson GA, Zhao W.

Int J Environ Res Public Health. 2014 Aug 25;11(9):8645-60. doi: 10.3390/ijerph110908645.

36.

Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain.

Sun J, Wei Y, Rauf A, Zhang Y, Ma Y, Zhang X, Shilo K, Yu Q, Saif YM, Lu X, Yu L, Li J.

J Virol. 2014 Nov;88(21):12348-63. doi: 10.1128/JVI.01095-14. Epub 2014 Aug 13.

37.

TRIM72 is required for effective repair of alveolar epithelial cell wounding.

Kim SC, Kellett T, Wang S, Nishi M, Nagre N, Zhou B, Flodby P, Shilo K, Ghadiali SN, Takeshima H, Hubmayr RD, Zhao X.

Am J Physiol Lung Cell Mol Physiol. 2014 Sep 15;307(6):L449-59. doi: 10.1152/ajplung.00172.2014. Epub 2014 Aug 8.

38.

C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.

Wani N, Nasser MW, Ahirwar DK, Zhao H, Miao Z, Shilo K, Ganju RK.

Breast Cancer Res. 2014 May 29;16(3):R54. doi: 10.1186/bcr3665.

39.
40.

Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic study.

Ströbel P, Zettl A, Shilo K, Chuang WY, Nicholson AG, Matsuno Y, Gal A, Laeng RH, Engel P, Capella C, Marino M, Chan JK, Rosenwald A, Travis W, Franks TJ, Ellenberger D, Schaefer IM, Marx A.

Genes Chromosomes Cancer. 2014 Sep;53(9):738-49. doi: 10.1002/gcc.22183. Epub 2014 Apr 25.

PMID:
24764238
41.

Y-chromosome status identification suggests a recipient origin of posttransplant non-small cell lung carcinomas: chromogenic in situ hybridization analysis.

Chen W, Brodsky SV, Zhao W, Otterson GA, Villalona-Calero M, Satoskar AA, Hasan A, Pelletier R, Ivanov I, Ross P, Nadasdy T, Shilo K.

Hum Pathol. 2014 May;45(5):1065-70. doi: 10.1016/j.humpath.2014.01.003. Epub 2014 Jan 23.

42.

Anaplastic papillary glioneuronal tumor with extraneural metastases.

Bourekas EC, Bell SD, Ladwig NR, Gandhe AR, Shilo K, McGregor JM, Lehman NL, Newton HB.

J Neuropathol Exp Neurol. 2014 May;73(5):474-6. doi: 10.1097/NEN.0000000000000061. Review. No abstract available.

PMID:
24709681
43.

Thymoma and parathyroid adenoma: false-positive imaging and intriguing laboratory test results.

Cunningham LC, Yu JG, Shilo K, Tang B, Nair L, Daniel VC, Old MO.

JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):369-73. doi: 10.1001/jamaoto.2013.6780.

PMID:
24557446
44.

mRNA cap methylation influences pathogenesis of vesicular stomatitis virus in vivo.

Ma Y, Wei Y, Zhang X, Zhang Y, Cai H, Zhu Y, Shilo K, Oglesbee M, Krakowka S, Whelan SP, Li J.

J Virol. 2014 Mar;88(5):2913-26. doi: 10.1128/JVI.03420-13. Epub 2013 Dec 26.

45.

Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors.

Shilo K, Wu X, Sharma S, Welliver M, Duan W, Villalona-Calero M, Fukuoka J, Sif S, Baiocchi R, Hitchcock CL, Zhao W, Otterson GA.

Diagn Pathol. 2013 Dec 10;8:201. doi: 10.1186/1746-1596-8-201.

46.

Congenital pulmonary airway malformation presenting as unilateral cystic lung disease.

McLoney ED, Diaz PT, Tran J, Shilo K, Ghosh S.

Am J Respir Crit Care Med. 2013 Oct 15;188(8):1030-1. doi: 10.1164/rccm.201211-2005IM. No abstract available.

PMID:
24127801
47.

Diagnostic value of blood clot core during endobronchial ultrasound-guided transbronchial needle aspirate.

Amin EN, Russell CD, Shilo K, Islam S, Wood KL.

Lung. 2013 Jun;191(3):305-9. doi: 10.1007/s00408-013-9457-5. Epub 2013 Mar 31.

PMID:
23543355
48.

Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.

Sneh A, Deol YS, Ganju A, Shilo K, Rosol TJ, Nasser MW, Ganju RK.

Breast Cancer Res Treat. 2013 Apr;138(3):727-39. doi: 10.1007/s10549-013-2491-4. Epub 2013 Mar 28.

49.

Detection of silicone in lung tissue.

Lewin-Smith M, Kalasinsky V, Shilo K, Tomashefski J, Cropp A.

Arch Pathol Lab Med. 2012 Oct;136(10):1179-80; author reply 1180. No abstract available.

PMID:
23020716
50.

Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer.

Zhao W, Huang CC, Otterson GA, Leon ME, Tang Y, Shilo K, Villalona MA.

J Oncol. 2012;2012:957437. doi: 10.1155/2012/957437. Epub 2012 Apr 30.

Supplemental Content

Support Center